Literature DB >> 17487558

Possible involvement of TWIST in enhanced peritoneal metastasis of epithelial ovarian carcinoma.

Mikio Terauchi1, Hiroaki Kajiyama, Mamoru Yamashita, Mikihiko Kato, Hirohisa Tsukamoto, Tomokazu Umezu, Satoyo Hosono, Eiko Yamamoto, Kiyosumi Shibata, Kazuhiko Ino, Akihiro Nawa, Tetsuro Nagasaka, Fumitaka Kikkawa.   

Abstract

Loss of E-cadherin triggers peritoneal dissemination, leading to an adverse prognosis for most patients with epithelial ovarian carcinoma (EOC). Because TWIST mainly regulates the epithelial-to-mesenchymal transition and is one of the E-cadherin repressors, we investigated the possibility that TWIST expression affects peritoneal metastasis of EOC using siRNA technique. In the present study, we showed a correlation between TWIST expression and EOC cellular morphology. Furthermore, we demonstrated that the suppression of TWIST expression in EOC cells (HEY) alters the cellular morphology from a fibroblastic and motile phenotype to an epithelial phenotype, and inhibits the adhesion of these cells to mesothelial monolayers. To investigate the mechanism by which down-regulation of TWIST leads to inhibition of adhesion to mesothelial cells (MCs), expression of adhesion molecules (CD29, CD44 and CD54) were observed. Moreover, matrix metalloproteinase 2 and membrane type 1 matrix metalloproteinase, important markers associated with invasive and metastatic potential, were remarkably reduced. This findings suggests that reduced expression of TWIST suppresses the multistep process of peritoneal dissemination (detachment from the primary lesion, adhesion to MCs and invasion of MCs) and may be a potential therapeutic target for the treatment of this carcinoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17487558     DOI: 10.1007/s10585-007-9070-1

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  50 in total

1.  Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1.

Authors:  J Roose; G Huls; M van Beest; P Moerer; K van der Horn; R Goldschmeding; T Logtenberg; H Clevers
Journal:  Science       Date:  1999-09-17       Impact factor: 47.728

Review 2.  Epithelial cell plasticity in development and tumor progression.

Authors:  J P Thiery; D Chopin
Journal:  Cancer Metastasis Rev       Date:  1999       Impact factor: 9.264

Review 3.  Fibronectin and its integrin receptors in cancer.

Authors:  E Ruoslahti
Journal:  Adv Cancer Res       Date:  1999       Impact factor: 6.242

4.  The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.

Authors:  H C Crawford; B M Fingleton; L A Rudolph-Owen; K J Goss; B Rubinfeld; P Polakis; L M Matrisian
Journal:  Oncogene       Date:  1999-05-06       Impact factor: 9.867

5.  Ultrastructural localization of alpha-3 integrin subunit in malignant melanoma and adjacent epidermis.

Authors:  D Schumacher; G Schaumburg-Lever
Journal:  J Cutan Pathol       Date:  1999-08       Impact factor: 1.587

6.  beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer.

Authors:  T Brabletz; A Jung; S Dag; F Hlubek; T Kirchner
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

7.  Transforming growth factor-beta 1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase.

Authors:  H P Marti; L Lee; M Kashgarian; D H Lovett
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

8.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

9.  Transformation and tumor progression are frequently associated with expression of the alpha 3/beta 1 heterodimer in solid tumors.

Authors:  A Bartolazzi; C Cerboni; M R Nicotra; M Mottolese; A Bigotti; P G Natali
Journal:  Int J Cancer       Date:  1994-08-15       Impact factor: 7.396

10.  Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma.

Authors:  C F Sier; F J Kubben; S Ganesh; M M Heerding; G Griffioen; R Hanemaaijer; J H van Krieken; C B Lamers; H W Verspaget
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

View more
  31 in total

1.  Lentivirus-mediated RNA silencing of c-Met markedly suppresses peritoneal dissemination of gastric cancer in vitro and in vivo.

Authors:  Xiao-lei Wang; Xi-mei Chen; Jian-ping Fang; Chang-qin Yang
Journal:  Acta Pharmacol Sin       Date:  2012-03-12       Impact factor: 6.150

2.  Pituitary tumor transforming gene induces epithelial to mesenchymal transition by regulation of Twist, Snail, Slug, and E-cadherin.

Authors:  Parag P Shah; Sham S Kakar
Journal:  Cancer Lett       Date:  2011-07-13       Impact factor: 8.679

3.  Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance.

Authors:  Rachel A Davidowitz; Laura M Selfors; Marcin P Iwanicki; Kevin M Elias; Alison Karst; Huiying Piao; Tan A Ince; Michael G Drage; Judy Dering; Gottfried E Konecny; Ursula Matulonis; Gordon B Mills; Dennis J Slamon; Ronny Drapkin; Joan S Brugge
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

Review 4.  Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer : future possibilities for personalised treatment by use of biomarkers.

Authors:  E M V de Cuba; R Kwakman; M van Egmond; L J W Bosch; H J Bonjer; G A Meijer; E A te Velde
Journal:  Virchows Arch       Date:  2012-07-24       Impact factor: 4.064

Review 5.  Current treatment options for colon cancer peritoneal carcinomatosis.

Authors:  Tomoyoshi Aoyagi; Krista P Terracina; Ali Raza; Kazuaki Takabe
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

6.  Murine Experimental Model of Original Tumor Development and Peritoneal Metastasis via Orthotopic Inoculation with Ovarian Carcinoma Cells.

Authors:  Yoshihiro Koya; Hiroaki Kajiyama; Wenting Liu; Kiyosumi Shibata; Takeshi Senga; Fumitaka Kikkawa
Journal:  J Vis Exp       Date:  2016-12-09       Impact factor: 1.355

7.  p53-Pirh2 Complex Promotes Twist1 Degradation and Inhibits EMT.

Authors:  Yang Yang-Hartwich; Roslyn Tedja; Cai M Roberts; Jamie Goodner-Bingham; Carlos Cardenas; Marta Gurea; Natalia J Sumi; Ayesha B Alvero; Carlotta A Glackin; Gil Mor
Journal:  Mol Cancer Res       Date:  2018-08-21       Impact factor: 5.852

8.  Impact of positive ZEB1 expression in patients with epithelial ovarian carcinoma as an oncologic outcome-predicting indicator.

Authors:  Jun Sakata; Hiroaki Kajiyama; Shiro Suzuki; Fumi Utsumi; Kaoru Niimi; Ryuichiro Sekiya; Kiyosumi Shibata; Takeshi Senga; Fumitaka Kikkawa
Journal:  Oncol Lett       Date:  2017-07-24       Impact factor: 2.967

9.  Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusions.

Authors:  Sivan Elloul; Olga Vaksman; Helene Tuft Stavnes; Claes G Trope; Ben Davidson; Reuven Reich
Journal:  Clin Exp Metastasis       Date:  2010-03-07       Impact factor: 5.150

10.  Changes in the expression of E-cadherin repressors, Snail, Slug, SIP1, and Twist, in the development and progression of ovarian carcinoma: the important role of Snail in ovarian tumorigenesis and progression.

Authors:  Junko Yoshida; Akiko Horiuchi; Norihiko Kikuchi; Akiko Hayashi; Ryosuke Osada; Satoshi Ohira; Tanri Shiozawa; Ikuo Konishi
Journal:  Med Mol Morphol       Date:  2009-06-18       Impact factor: 2.309

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.